Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | acrosin | Starlite/ChEMBL | References |
Homo sapiens | protease, serine, 1 (trypsin 1) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Trypsin family protein | protease, serine, 1 (trypsin 1) | 247 aa | 287 aa | 21.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | von Willebrand factor type A domain containing protein | 0.0272 | 0.0159 | 0.0797 |
Loa Loa (eye worm) | von Willebrand factor domain-containing protein | 0.0272 | 0.0159 | 0.0797 |
Loa Loa (eye worm) | hypothetical protein | 0.0272 | 0.0159 | 0.0797 |
Loa Loa (eye worm) | hypothetical protein | 0.0272 | 0.0159 | 0.0797 |
Onchocerca volvulus | 0.0106 | 0.0045 | 0.2851 | |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 1.4654 | 1 | 1 |
Brugia malayi | Trypsin family protein | 0.0121 | 0.0055 | 0.0278 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0074 | 0.0023 | 0.0054 |
Brugia malayi | Zona pellucida-like domain containing protein | 0.0272 | 0.0159 | 0.0797 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0121 | 0.0055 | 0.0127 |
Loa Loa (eye worm) | hypothetical protein | 0.0121 | 0.0055 | 0.0278 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0121 | 0.0055 | 0.0127 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.6393 | 0.4347 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0272 | 0.0159 | 0.0797 |
Loa Loa (eye worm) | hypothetical protein | 0.0272 | 0.0159 | 0.0797 |
Echinococcus granulosus | voltage dependent calcium channel subunit | 0.6665 | 0.4533 | 0.4533 |
Schistosoma mansoni | hypothetical protein | 0.3442 | 0.2328 | 0.5355 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0068 | 0.0019 | 0.0095 |
Brugia malayi | Zona pellucida-like domain containing protein | 0.0272 | 0.0159 | 0.0797 |
Brugia malayi | von Willebrand factor type A domain containing protein | 0.0272 | 0.0159 | 0.0797 |
Onchocerca volvulus | 0.0272 | 0.0159 | 1 | |
Toxoplasma gondii | von Willebrand factor type A domain-containing protein | 0.0272 | 0.0159 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.0013 | 0.0064 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.3223 | 0.2178 | 0.501 |
Loa Loa (eye worm) | hypothetical protein | 0.0272 | 0.0159 | 0.0797 |
Brugia malayi | von Willebrand Factor | 0.0272 | 0.0159 | 0.0797 |
Loa Loa (eye worm) | hypothetical protein | 0.0272 | 0.0159 | 0.0797 |
Plasmodium falciparum | circumsporozoite- and TRAP-related protein | 0.0272 | 0.0159 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0272 | 0.0159 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0272 | 0.0159 | 0.0797 |
Brugia malayi | von Willebrand factor type A domain containing protein | 0.0272 | 0.0159 | 0.0797 |
Brugia malayi | von Willebrand factor type A domain containing protein | 0.0272 | 0.0159 | 0.0797 |
Toxoplasma gondii | microneme protein MIC2 | 0.0272 | 0.0159 | 0.5 |
Onchocerca volvulus | 0.0272 | 0.0159 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0272 | 0.0159 | 0.0797 |
Brugia malayi | von Willebrand factor type A domain containing protein | 0.0272 | 0.0159 | 0.0797 |
Loa Loa (eye worm) | hypothetical protein | 0.0272 | 0.0159 | 0.0797 |
Plasmodium vivax | circumsporozoite- and TRAP-related protein, putative | 0.0272 | 0.0159 | 0.5 |
Brugia malayi | Cache domain containing protein | 0.295 | 0.1991 | 1 |
Plasmodium falciparum | thrombospondin-related anonymous protein | 0.0272 | 0.0159 | 0.5 |
Treponema pallidum | 76K protein | 0.0272 | 0.0159 | 0.5 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0068 | 0.0019 | 0.0095 |
Loa Loa (eye worm) | von Willebrand factor type A domain-containing protein | 0.0272 | 0.0159 | 0.0797 |
Onchocerca volvulus | 0.0272 | 0.0159 | 1 | |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0068 | 0.0019 | 0.0019 |
Echinococcus multilocularis | collagen alpha 1(VII) chain | 0.0272 | 0.0159 | 0.0159 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0272 | 0.0159 | 1 |
Schistosoma mansoni | serine-rich repeat protein | 0.3442 | 0.2328 | 0.5355 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0068 | 0.0019 | 0.0019 |
Loa Loa (eye worm) | hypothetical protein | 0.0272 | 0.0159 | 0.0797 |
Loa Loa (eye worm) | hypothetical protein | 0.0121 | 0.0055 | 0.0278 |
Brugia malayi | hypothetical protein | 0.0272 | 0.0159 | 0.0797 |
Onchocerca volvulus | 0.0272 | 0.0159 | 1 | |
Onchocerca volvulus | 0.0272 | 0.0159 | 1 | |
Onchocerca volvulus | 0.0272 | 0.0159 | 1 | |
Plasmodium vivax | dynein-related AAA-type ATPase, putative | 0.0272 | 0.0159 | 0.5 |
Onchocerca volvulus | 0.0121 | 0.0055 | 0.3491 | |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.6665 | 0.4533 | 0.4533 |
Loa Loa (eye worm) | CUTiclin family member | 0.0272 | 0.0159 | 0.0797 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0272 | 0.0159 | 0.5 |
Plasmodium falciparum | von Willebrand factor A domain-related protein | 0.0272 | 0.0159 | 0.5 |
Treponema pallidum | hypothetical protein | 0.0272 | 0.0159 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0272 | 0.0159 | 0.5 |
Plasmodium vivax | von Willebrand factor A domain-related protein, putative | 0.0272 | 0.0159 | 0.5 |
Brugia malayi | von Willebrand factor type A domain containing protein | 0.0272 | 0.0159 | 0.0797 |
Entamoeba histolytica | elongation factor-2 kinase, putative | 0.0272 | 0.0159 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.295 | 0.1991 | 1 |
Brugia malayi | von Willebrand factor type A domain containing protein | 0.0272 | 0.0159 | 0.0797 |
Loa Loa (eye worm) | hypothetical protein | 0.0272 | 0.0159 | 0.0797 |
Brugia malayi | von Willebrand factor type A domain containing protein | 0.0272 | 0.0159 | 0.0797 |
Echinococcus granulosus | collagen alpha 1VII chain | 0.0272 | 0.0159 | 0.0159 |
Schistosoma mansoni | hypothetical protein | 0.0272 | 0.0159 | 0.0365 |
Brugia malayi | Transmembrane cell adhesion receptor mua-3 precursor, putative | 0.0272 | 0.0159 | 0.0797 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0272 | 0.0159 | 0.0797 |
Loa Loa (eye worm) | CUTiclin-Like family member | 0.0272 | 0.0159 | 0.0797 |
Loa Loa (eye worm) | hypothetical protein | 0.0272 | 0.0159 | 0.0797 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0074 | 0.0023 | 0.0054 |
Loa Loa (eye worm) | hypothetical protein | 0.0272 | 0.0159 | 0.0797 |
Plasmodium vivax | thrombospondin-related anonymous protein | 0.0272 | 0.0159 | 0.5 |
Onchocerca volvulus | 0.0272 | 0.0159 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0272 | 0.0159 | 0.0797 |
Schistosoma mansoni | hypothetical protein | 0.0272 | 0.0159 | 0.0365 |
Entamoeba histolytica | hypothetical protein | 0.0272 | 0.0159 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
I50 (binding) | = 11400000000 M | Inhibition of human acrosin and control activity being 11.3 umol/min/mg | ChEMBL. | 3514912 |
I50 (binding) | = 22300000000 M | Inhibition of human trypsin and the control activity being 7.3 umol/min/mg | ChEMBL. | 3514912 |
IC50 (binding) | = 0.0000000114 M | Inhibition of human acrosin and control activity being 11.3 umol/min/mg | ChEMBL. | 3514912 |
IC50 (binding) | = 0.0000000223 M | Inhibition of human trypsin and the control activity being 7.3 umol/min/mg | ChEMBL. | 3514912 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.